European Union (EU) officials had raided a number of pharmaceutical companies for antitrust concern, the European Commission said on Friday.
The unannounced inspections were carried out on Tuesday at the premises of a limited number of companies active in the pharmaceutical sector in several EU member states.
The commission said it had reason to believe that the companies concerned may have acted individually or jointly, notably to delay generic entry for a particular medicine.
"If confirmed, this could be a potential violation of EU antitrust rules that prohibit restrictive business practices and the abuse of a dominant market position," it said.
Unannounced inspections are a preliminary step in the EU's procedure against suspected anticompetitive practices, which the commission said do not mean that the companies are guilty of anti-competitive behavior nor does it prejudge the outcome of the investigation itself.
No comments:
Post a Comment